HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles E Geyer Selected Research

neratinib

12/2013A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles E Geyer Research Topics

Disease

96Breast Neoplasms (Breast Cancer)
02/2024 - 01/2004
39Neoplasms (Cancer)
02/2024 - 07/2003
9Pathologic Complete Response
06/2023 - 06/2008
6Triple Negative Breast Neoplasms
11/2021 - 07/2014
6Neutropenia
09/2015 - 07/2003
4Fatigue
02/2024 - 08/2011
4Heart Failure
01/2023 - 01/2004
4Cardiotoxicity
01/2023 - 01/2004
4Amenorrhea
02/2022 - 06/2010
3Hypertension (High Blood Pressure)
12/2017 - 01/2012
3Hand-Foot Syndrome
09/2015 - 08/2011
2Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2012
2Adenocarcinoma
01/2021 - 09/2005
2Left Ventricular Dysfunction
01/2019 - 01/2012
2Mucositis
01/2012 - 08/2011
2Febrile Neutropenia
02/2010 - 06/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2008 - 09/2005
1Leukemia
02/2024
1Chronic Disease (Chronic Diseases)
02/2024
1Genomic Instability
11/2021
1Cognitive Dysfunction
10/2020
1Breast Diseases (Breast Disease)
01/2020
1Nausea
01/2020
1Constipation
01/2020
1Vomiting
01/2020
1Residual Neoplasm
01/2019
1Back Pain (Backache)
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Arthralgia (Joint Pain)
01/2019
1Second Primary Neoplasms (Neoplasms, Second)
07/2018
1Hyperlipidemias (Hyperlipidemia)
12/2017
1Heart Diseases (Heart Disease)
12/2017
1Sudden Death
09/2015
1Endocarditis
09/2015
1Margins of Excision
02/2014
1Unilateral Breast Neoplasms
02/2014

Drug/Important Bio-Agent (IBA)

34Trastuzumab (Herceptin)FDA Link
06/2023 - 10/2005
20Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 01/2004
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 10/2005
19Hormones (Hormone)IBA
02/2024 - 04/2008
17AnthracyclinesIBA
02/2024 - 11/2005
16ErbB Receptors (EGF Receptor)IBA
02/2024 - 11/2005
16TamoxifenFDA LinkGeneric
11/2023 - 08/2006
14Paclitaxel (Taxol)FDA LinkGeneric
06/2023 - 01/2004
13B 31IBA
01/2023 - 10/2005
11Estrogen ReceptorsIBA
07/2023 - 05/2006
11Lapatinib (GW572016)FDA Link
06/2023 - 12/2006
11human ERBB2 proteinIBA
01/2023 - 11/2005
11Docetaxel (Taxotere)FDA Link
08/2017 - 05/2006
10Capecitabine (Xeloda)FDA Link
09/2015 - 12/2006
8taxaneIBA
01/2020 - 12/2006
6Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2008
6exemestane (Aromasin)FDA Link
01/2023 - 04/2008
5Aromatase InhibitorsIBA
02/2024 - 07/2014
5Bevacizumab (Avastin)FDA Link
07/2017 - 08/2011
5GemcitabineFDA Link
09/2015 - 01/2004
4Epirubicin (Ellence)FDA LinkGeneric
02/2022 - 06/2008
3Letrozole (Femara)FDA LinkGeneric
02/2024 - 01/2019
3olaparibIBA
02/2024 - 01/2021
3Dihydrotachysterol (AT 10)IBA
07/2023 - 08/2006
3Progesterone Receptors (Progesterone Receptor)IBA
01/2023 - 04/2012
3Epidermal Growth Factor (EGF)IBA
01/2023 - 12/2013
3Estrogens (Estrogen)FDA Link
01/2023 - 04/2012
3Ado-Trastuzumab EmtansineIBA
09/2022 - 01/2019
3RNA (Ribonucleic Acid)IBA
11/2021 - 06/2008
3Carboplatin (JM8)FDA LinkGeneric
11/2021 - 01/2018
2Fluorouracil (Carac)FDA LinkGeneric
02/2022 - 02/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2021 - 01/2018
2veliparibIBA
11/2021 - 01/2018
2Pemetrexed (MTA)FDA Link
01/2016 - 09/2005
2ParaffinIBA
11/2015 - 11/2011
2Taxoids (Taxanes)IBA
01/2012 - 06/2010
2Messenger RNA (mRNA)IBA
11/2011 - 12/2008
2Proteins (Proteins, Gene)FDA Link
11/2011 - 12/2008
2desintegron BIBA
05/2011 - 04/2010
2Monoclonal AntibodiesIBA
03/2009 - 10/2008
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
02/2024
1Antineoplastic Agents (Antineoplastics)IBA
01/2023
1N-acetyltalosaminuronic acid (NAT)IBA
01/2023
1TRPC6 Cation ChannelIBA
01/2023
1PlatinumIBA
11/2021
1Poly Adenosine Diphosphate RiboseIBA
01/2021
1130-nm albumin-bound paclitaxelIBA
01/2019
1Cytotoxins (Cytolysins)IBA
01/2019
1Maytansine (Maitansine)IBA
01/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015
1neratinibIBA
12/2013

Therapy/Procedure

54Therapeutics
02/2024 - 01/2004
33Drug Therapy (Chemotherapy)
07/2023 - 01/2004
23Neoadjuvant Therapy
01/2023 - 06/2008
20Adjuvant Chemotherapy
02/2024 - 01/2004
8Segmental Mastectomy (Lumpectomy)
06/2022 - 06/2008
3Radiotherapy
02/2024 - 02/2014
3Mastectomy (Mammectomy)
02/2014 - 06/2008
2Simple Mastectomy
06/2022 - 10/2008
2Combination Drug Therapy (Combination Chemotherapy)
11/2014 - 09/2013
2Aftercare (After-Treatment)
12/2008 - 12/2006